These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30505585)
1. Multiple primary malignancies in patients with anal squamous cell carcinoma. Li D; Yegya-Raman N; Kim S; Ganesan S; Sayan M; August D; Spencer K; Hathout L; Maloney-Patel N; Malhotra U; Yue NJ; Jabbour SK J Gastrointest Oncol; 2018 Oct; 9(5):853-857. PubMed ID: 30505585 [TBL] [Abstract][Full Text] [Related]
2. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Nelson RA; Lai LL Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917 [TBL] [Abstract][Full Text] [Related]
3. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy. Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167 [TBL] [Abstract][Full Text] [Related]
4. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Jain KS; Sikora AG; Baxi SS; Morris LG Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883 [TBL] [Abstract][Full Text] [Related]
5. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis. Jia H; Li Q; Yuan J; Sun X; Wu Z Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509 [TBL] [Abstract][Full Text] [Related]
6. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma. Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848 [TBL] [Abstract][Full Text] [Related]
7. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107 [TBL] [Abstract][Full Text] [Related]
8. Progress in the treatment of anal cancer: an overview of the latest investigational drugs. Yu J; Kim RD Expert Opin Investig Drugs; 2024 Feb; 33(2):145-157. PubMed ID: 38275174 [TBL] [Abstract][Full Text] [Related]
9. Optimal management of squamous cell carcinoma of the anal canal: where are we now? Eng C; Ahmed S Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728 [TBL] [Abstract][Full Text] [Related]
10. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States. Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963 [TBL] [Abstract][Full Text] [Related]
11. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519 [TBL] [Abstract][Full Text] [Related]
12. How I treat anal squamous cell carcinoma. Martini G; Arrichiello G; Borrelli C; Poliero L; Martinelli E ESMO Open; 2020 Sep; 4(Suppl 2):e000711. PubMed ID: 32883674 [TBL] [Abstract][Full Text] [Related]
13. The promise of immunotherapy in anal squamous cell carcinoma: a novel approach for an orphan disease. Johnson B; Eng C Clin Adv Hematol Oncol; 2017 Dec; 15(12):968-961. PubMed ID: 29315288 [TBL] [Abstract][Full Text] [Related]
14. Metastatic Anal Cancer and Novel Agents. Morris V; Eng C Surg Oncol Clin N Am; 2017 Jan; 26(1):133-142. PubMed ID: 27889032 [TBL] [Abstract][Full Text] [Related]
15. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study). Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. Tachezy R; Jirasek T; Salakova M; Ludvikova V; Kubecova M; Horak L; Mandys V; Hamsikova E APMIS; 2007 Mar; 115(3):195-203. PubMed ID: 17367464 [TBL] [Abstract][Full Text] [Related]
17. Second primary anal and oropharyngeal cancers in cervical cancer survivors. Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108 [TBL] [Abstract][Full Text] [Related]
18. Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy. Zhang B; Guo K; Zheng X; Sun L; Shen M; Ruan S Front Oncol; 2020; 10():1154. PubMed ID: 32766153 [No Abstract] [Full Text] [Related]
19. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. Chang DT; Chapman C; Shen J; Su Z; Koong AC Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029 [TBL] [Abstract][Full Text] [Related]
20. Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience. Tomassi MJ; Abbas MA; Klaristenfeld DD Int J Colorectal Dis; 2019 Jan; 34(1):47-54. PubMed ID: 30244347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]